Johnson & Johnson Q4 Report: huge loss to tax provision but strong sales growth
By Yanchun (Roxanne) Liu Johnson & Johnson (NYSE: JNJ), one of the world’s largest pharmaceutical makers, reported Tuesday a huge net loss occasioned by a tax charge on cash outside the United States, along with a healthy increase in adjusted quarterly earnings that slightly beat Wall Street expectations. The stock dropped 4.3 percent. The New […]
